Bellevue, WA, United States

Innovative Healthcare

invhc.com
Bellevue, WA, United States
SEARCH FILTERS
Time filter
Source Type

Patent
Innovative Healthcare | Date: 2016-08-29

A patient care room and method of treating a patient in a patient care room includes a patient treatment area that is configured to accept a patient support, such as a bed, and a waste containment room that is walled from said treatment area. The waste containment room has a toilet and a door that selectively separates the waste containment area from the treatment area and a decontaminating unit. The decontaminating unit is capable of killing common pathogens. An airflow system discharges air from the waste containment room to outside of the patient care room thereby creating a negative pressure in the waste containment room with respect to the treatment area.


Hu Y.,Harvard University | Hu Y.,Temple University | Park K.,Harvard University | Park K.,University of Miami | And 11 more authors.
Neuron | Year: 2012

Loss of retinal ganglion cells (RGCs) accounts for visual function deficits after optic nerve injury, but how axonal insults lead to neuronal death remains elusive. By using an optic nerve crush model that results in the death of the majority of RGCs, we demonstrate that axotomy induces differential activation of distinct pathways of the unfolded protein response in axotomized RGCs. Optic nerve injury provokes a sustained CCAAT/enhancer binding homologous protein (CHOP) upregulation, and deletion of CHOP promotes RGC survival. In contrast, IRE/XBP-1 is only transiently activated, and forced XBP-1 activation dramatically protects RGCs from axon injury-induced death. Importantly, such differential activations of CHOP and XBP-1 and their distinct effects on neuronal cell death are also observed in RGCs with other types of axonal insults, such as vincristine treatment and intraocular pressure elevation, suggesting a new protective strategy for neurodegeneration associated with axonal damage. © 2012 Elsevier Inc.


News Article | December 9, 2016
Site: www.PR.com

Washington, DC, December 09, 2016 --( New Board Members: · Sunny Ramchandani, MD, Deputy Chief Medical Officer, Aetna · Raymond Fabius, MD, Co-Founder and President, Health Next · Michelle Hart-Guyot, Co-Founder and Vice President, Innovative Healthcare Delivery · Christopher Long, Executive Vice President and Chief Operating Officer, AxisPoint Health · David Nash, MD, MBA, Dean, Jefferson School of Population Health, Honorary, Non-Voting Board Member PHA members also elected the following members of the Executive Committee: · Board Chair: Rose Maljanian, Chairman & CEO, HealthCAWS, Inc. · Past Board Chair: Christobel Selecky, Principal, Population Health Strategies · Chair Elect: Brenda Schmidt, Founder and CEO, Solera Health · Secretary: Susan Riley, President and CEO, TripleCare · Chair, Quality and Research: Mary Jane Osmick, MD, Vice President and Medical Director, American Specialty Health · Chair, Government Affairs: Sean McManamy, Senior Strategy, Marketing and Product Leader in Employee Benefits and Healthcare, HealthFitness · At Large: Sandeep Wahdwa, MD, MBA, DMO and Vice President of Care & Delivery Management, Noridian Healthcare Solutions Board members continuing to serve include: · Anthony Akosa, MD, System Medical Director, Franciscan Health · Michael Ansel, Chief Growth Officer, Matrix Medical Network · Jan Berger, MD, Chief Executive Officer, Health Intelligence Partner · John Brooks, MD, Chief Executive Officer, Healthcare Capital, LLC · Andre Gibrail, Operations Director, Healthways Brazil · Ron Guziak, President and CEO, Sun Health · Adam Kaufman, PhD, President and CEO, Canary Health · Sam Meckey, Chief Operating Officer, Care Management & Advocacy, Optum · John Robitscher, President and CEO, National Association of Chronic Disease Directors · Michael Taylor, Senior Vice President & GM at Truven Health Analytics, an IBM Company The PHA Board thanks its many committed members advancing Population Health for individuals and communities every day. If you are not a PHA member. Join the Population Health Alliance today: www.populationhealthalliance.org/images/applications/PHAMembershipApp2016_Fillable.pdf About the Population Health Alliance The Population Health Alliance (PHA) is the industry’s only multi stakeholder professional and trade association solely focused on population health. The organization has nearly 100 members representing stakeholders from across the health care delivery system that seek to improve health outcomes, optimize medical and administrative spend, and drive affordability. Through its robust advocacy, research and education initiatives, the PHA offers members a forum to advance shared learning and applied research to further innovation and establish best practices in the population health field. Visit http://www.populationhealthalliance.org to learn more. Follow at @PHAVoice. Washington, DC, December 09, 2016 --( PR.com )-- Population Health Alliance (PHA), a leading non-profit organization dedicated to advancing the principles of population health, recently announced that four new members and one honorary member have been appointed to its Board of Directors. PHA members approved the appointments at the PHA Forum 2016 on November 10. Members also elected Rose Maljanian, Chairman & CEO of HealthCAWS, Inc., as Chairman of the Board.New Board Members:· Sunny Ramchandani, MD, Deputy Chief Medical Officer, Aetna· Raymond Fabius, MD, Co-Founder and President, Health Next· Michelle Hart-Guyot, Co-Founder and Vice President, Innovative Healthcare Delivery· Christopher Long, Executive Vice President and Chief Operating Officer, AxisPoint Health· David Nash, MD, MBA, Dean, Jefferson School of Population Health, Honorary, Non-Voting Board MemberPHA members also elected the following members of the Executive Committee:· Board Chair: Rose Maljanian, Chairman & CEO, HealthCAWS, Inc.· Past Board Chair: Christobel Selecky, Principal, Population Health Strategies· Chair Elect: Brenda Schmidt, Founder and CEO, Solera Health· Secretary: Susan Riley, President and CEO, TripleCare· Chair, Quality and Research: Mary Jane Osmick, MD, Vice President and Medical Director, American Specialty Health· Chair, Government Affairs: Sean McManamy, Senior Strategy, Marketing and Product Leader in Employee Benefits and Healthcare, HealthFitness· At Large: Sandeep Wahdwa, MD, MBA, DMO and Vice President of Care & Delivery Management, Noridian Healthcare SolutionsBoard members continuing to serve include:· Anthony Akosa, MD, System Medical Director, Franciscan Health· Michael Ansel, Chief Growth Officer, Matrix Medical Network· Jan Berger, MD, Chief Executive Officer, Health Intelligence Partner· John Brooks, MD, Chief Executive Officer, Healthcare Capital, LLC· Andre Gibrail, Operations Director, Healthways Brazil· Ron Guziak, President and CEO, Sun Health· Adam Kaufman, PhD, President and CEO, Canary Health· Sam Meckey, Chief Operating Officer, Care Management & Advocacy, Optum· John Robitscher, President and CEO, National Association of Chronic Disease Directors· Michael Taylor, Senior Vice President & GM at Truven Health Analytics, an IBM CompanyThe PHA Board thanks its many committed members advancing Population Health for individuals and communities every day. If you are not a PHA member. Join the Population Health Alliance today: www.populationhealthalliance.org/images/applications/PHAMembershipApp2016_Fillable.pdfAbout the Population Health AllianceThe Population Health Alliance (PHA) is the industry’s only multi stakeholder professional and trade association solely focused on population health. The organization has nearly 100 members representing stakeholders from across the health care delivery system that seek to improve health outcomes, optimize medical and administrative spend, and drive affordability. Through its robust advocacy, research and education initiatives, the PHA offers members a forum to advance shared learning and applied research to further innovation and establish best practices in the population health field.Visit http://www.populationhealthalliance.org to learn more. Follow at @PHAVoice. Click here to view the list of recent Press Releases from Population Health Alliance


News Article | November 22, 2016
Site: www.prweb.com

Casenet®, LLC, a leading provider of extensible population health and care management solutions, was this month announced as a winner of the United Kingdom’s Global Health and Pharma (GHP) 2016 Healthcare & Pharmaceutical Awards. Casenet was recognized for Best Care Management Software Provider and Most Innovative Healthcare Software Solution for Casenet’s TruCare platform. Each Year, GHP’s Healthcare & Pharmaceuticals Awards seek to chronicle the individuals, departments and organizations, both corporate and public, that work tirelessly throughout the healthcare industry. GHP prides itself on the validity of its awards and winners. The awards are given solely on merit to commend those most deserving for their ingenuity and hard work, distinguishing them from their competitors. “The healthcare and pharmaceuticals market is the lifeblood of our society, and therefore it is a true honor to put the spotlight on our deserving winners. I would like to wish them every success in the future,” said Coordinator Naomi Douglas regarding the awards. Casenet was selected as a standout organization for its international offering of comprehensive, best-in-class, and enterprise population health and care management solutions that improve care coordination and the quality and delivery of care. Casenet’s TruCare solution received the award for supporting some of the highest acuity patients in the industry across a large number of diverse organizations and for the vision and continuous innovation of the Casenet development and leadership teams. Significant benefits and features recognized by GHP in light of the awards include: Casenet CEO Peter Masanotti graciously accepted both awards from GHP stating that the awards further validate the mission and purpose of Casenet, which is “to help all individuals achieve maximum health through appropriate health management, thereby providing better outcomes at a lower cost.” To learn more about Casenet’s awards and to gain insight into the working practices of the “best of the best” in the health and pharma industries, please visit the GHP website where you can access the winners supplement. About GHP GHP is a quarterly magazine brought to you by AI Global Media Ltd, a publishing house that has reinvigorated corporate finance news and reporting. Its topical news articles make it a valued read, and this readability ensures that advertisers will benefit greatly from their investment. Established to enhance communication networks and collaboration across all themes and disciplines within 3 main categories; Human, Animal & Environmental Health. About Casenet, LLC Casenet provides a comprehensive suite of extensible, enterprise care management software and services solutions for commercial, Medicaid, Medicare, TPA, provider/ACO and specialty provider organizations. These solutions improve care coordination and the quality and delivery of care through enhanced case, disease, utilization, home and community-based services management and population management. Casenet supports small to very large enterprise customers requiring tremendous scalability for many lines of business and comprehensive configuration for each targeted member population. Casenet solutions help organizations meet unique business requirements, adapt quickly to changing market and regulatory dynamics, identify and target populations with unique risk characteristics and deploy specific care management programs for those members — taking the first step toward better individual health and total population health management. For more information, visit http://www.casenetllc.com.


Freeman D.K.,Innovative Healthcare | Freeman D.K.,Harvard University | Fried S.I.,Innovative Healthcare | Fried S.I.,Harvard University
Journal of Neural Engineering | Year: 2011

Retinal prostheses aim to restore functional vision to those blinded by outer retinal diseases using electric stimulation of surviving neurons. Previous work indicates that repetitive stimulation with stimuli that activate the synaptic network reduces the sensitivity of retinal neurons to further stimulation. Such desensitization may contribute to the fading of visual percepts over time reported by human subjects. Here, we show that desensitization may be more complex than previously considered. We recorded spike trains from rabbit retinal ganglion cells and found that desensitization persists in the presence of inhibitory blockers (strychnine and picrotoxin), indicating amacrine cell inhibition is not solely responsible for reducing sensitivity in response to electric stimulation. The threshold for direct activation of the ganglion cell changes little during the simultaneous desensitization of the synaptically mediated response, indicating that desensitization likely occurs upstream of the spike generator. In addition to rapid desensitization acting over hundreds of milliseconds (τ = 176.4 ± 8.8 ms), we report the presence of slow acting desensitization with a time course of seconds (τ = 14.0 ± 1.1 s). The time courses of the two components of desensitization that we found are similar to the two phases of brightness fading seen in human subjects. This suggests that the reduction in ganglion cell firing due to desensitization may be responsible for the fading of visual percepts over time in response to prosthetic stimulation. © 2011 IOP Publishing Ltd.


In an embodiment, a first communication that is an electronic hospital census and/or an outpatient authorization report is received by a control device operated by an entity that is a different entity than the hospital. The first communication identifies an individual admitted to a hospital and/or individual scheduled for an elective outpatient procedure. The control device stores a file for the patient identifying a service needed by the patient, and the service is a pre-procedure service, a post-procedure service, a pre-discharge service, and/or a post-discharge service. The entity that operates the control device performs a second communication that coordinates the service from a provider that is a different entity than the entity that operates the control device. The second communication is performed at a time that is at least one of before admission to the hospital, at admission to the hospital, before the procedure, after the procedure, or at discharge.


Patent
Innovative Healthcare | Date: 2015-10-30

Occlusive tissue dressings and methods including an elastomeric drape and a liquid component, at least partially cross-linked at least after one of drying and curing, suitable for application at a dressing-to-skin interface in order to create a substantially air-tight seal. The same or a different liquid component may be applied by a user at a tube-to-dressing interface in order to create a similar air-tight seal around the tube, if not occlusively sealed during its manufacture.


Patent
Innovative Healthcare | Date: 2015-12-10

Tapes and methods including an unbacked construction of at least one liquid layer adhesive that has been at least one of dried and cured. Occlusive tissue dressings, tapes and methods including an elastomeric drape and, for backed drapes and some unbacked drapes, a liquid component, at least partially cross-linked at least after one of drying and curing, suitable for application at a dressing-to-skin interface in order to create a substantially air-tight seal. The same or a different liquid component may be applied by a user at a tube-to-dressing interface of an elastomeric drape to create a similar air-tight seal around the tube, if not occlusively sealed during its manufacture. Featured are unbacked tapes, a drape with liquid sealant component, a liquid layered drape with liquid sealant component, and a liquid layered drape.


Trademark
Innovative Healthcare | Date: 2014-07-31

Gloves for medical and dental use.

Loading Innovative Healthcare collaborators
Loading Innovative Healthcare collaborators